Does marrow fibrosis influence post-transplant outcome in patients with myelodysplastic syndrome (MDS)?

被引：0
|
作者：
Scott, BL
Chyou, F
Deeg, HJ
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Seattle, WA USA
来源：
EXPERIMENTAL HEMATOLOGY | 2004年 / 32卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
71
引用
下载
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [1] Impact of pretransplant neutropenia on post-transplant outcome in patients with Myelodysplastic syndrome (MDS).
    Scott, Bart L.
    Park, J. Y.
    Storer, B.
    Marr, K. A.
    Boeclch, M.
    Deeg, H. Joachim
    BLOOD, 2006, 108 (11) : 181A - 181A
  • [2] Pre-Transplant Therapy for Patients with Myelodysplastic Syndrome and Post-Transplant Outcome
    Farhan, Shatha
    McKinnon, Rick
    Szymanski, Sarah
    Neme, Klodiana
    Mikulandric, Nancy
    Peres, Edward
    Janakiraman, Nalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S288 - S288
  • [3] Prognostic Factors for Post-Transplant Outcomes in Patients with Myelodysplastic Syndromes (MDS)
    Bejanyan, Nelli
    Maciejewski, Jaroslaw P.
    Rybicki, Lisa
    O'Keefe, Christine L.
    Nyatanga, Nolyn
    Tench, Shawnda
    Sekeres, Mikkael A.
    Advani, Anjali S.
    Saunthararajah, Yogen
    Duong, Hien
    Sobecks, Ronald
    Kalaycio, Matt
    Bolwell, Brian J.
    Copelan, Edward A.
    BLOOD, 2011, 118 (21) : 881 - 881
  • [4] Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome
    Modi, Dipenkumar
    Kim, Seongho
    Singh, Vijendra
    Ayash, Lois
    Alavi, Asif
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Deol, Abhinav
    LEUKEMIA & LYMPHOMA, 2019, 60 (11) : 2762 - 2770
  • [5] Pre-Transplant Hypomethylating Agents Do Not Influence Post-Transplant Outcomes in Myelodysplastic Syndrome
    Modi, Dipenkumar
    Kim, Seongho
    Singh, Vijendra
    Alavi, Asif
    Ayash, Lois
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Deol, Abhinav
    BLOOD, 2018, 132
  • [6] Persistent Fibrosis in Bone Marrow Biopsies Post-Transplant for Myeloid Neoplasms with Increased Fibrosis: What Does it Mean?
    Gupta, Srishti
    Chaer, Firas
    Courville, Elizabeth
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1141 - S1142
  • [7] Using engineered allografts to improve transplant outcome in myelodysplastic syndrome (MDS).
    ODonnell, PV
    Noga, SJ
    Grever, M
    Vogelsang, GB
    Jones, RJ
    BLOOD, 1997, 90 (10) : 1009 - 1009
  • [8] Genomic Subgroups Impact Post-Transplant Survival in Patients with Myelodysplastic Syndrome: A CIBMTR Analysis
    Zhang, Tao
    Auer, Paul
    Spellman, Stephen R.
    Fretham, Caitrin
    Saber, Wael
    Bolon, Yung-Tsi
    BLOOD, 2021, 138 : 3678 - +
  • [9] Does continuation of antifibrotics before lung transplantation influence post-transplant outcomes in patients with idiopathic pulmonary fibrosis?
    Zhu, Michael Z. L.
    Huang, Joanna Yilin
    Liu, David Hongwei
    Snell, Gregory, I
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 34 (02) : 250 - 254
  • [10] Response to azacitidine in patients with myelodysplastic syndrome with marrow fibrosis
    Juvvadi, R.
    Rossetti, J. M.
    Shadduck, R. K.
    Kaplan, R. B.
    Kennedy, M.
    Kramer, W.
    Lister, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345